Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Kronos Bio
689 Fifth Avenue, 12th Floor
New York, NY 10022
http://www.kronosbio.com/

Kronos Bio is dedicated to the research and development of first-in-class therapies that modulate historically recalcitrant cancer targets. Leveraging industry-leading research into high-throughput screening strategies for chemical modulators of transcription factors and other challenging targets in oncology, Kronos utilizes its small molecule microarray (SMM) platform and extensive know-how in biological assay development to pursue novel therapies against some of the most important and intractable targets in cancer research.

Key Contact
Name
Norbert Bischofberger, Ph.D.
Title
President & CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
05/23/18 $18,000,000 Seed BellCo Capital
John Martin, Ph.D.
Norbert Bischofberger, Ph.D.
Omega Funds
Vida Ventures
undisclosed